• POTHURAJU NARESH Department of Pharmaceutical Analysis, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)-Autonomous, Anantapur, Andhra Pradesh, India 515721 https://orcid.org/0000-0001-7956-3276
  • K. VINOD KUMAR Department of Pharmaceutical Analysis, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)-Autonomous, Anantapur, Andhra Pradesh, India 515721




HPLC, Leflunomide, Validation, Tablet


Objective: To develop a Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) method for Leflunomide using rapid, cheap, economical, and less composition of the mobile phase. To validate the method's specificity, linearity, precision, accuracy, robustness, and ruggedness were all validated as per regulatory requirements ICH Q2 [R1] guidelines.

Methods: The method employed solving of Development and validation based on the measurement of absorbance at one wavelength, 251 nm, λ max, Inertsil-ODS C18 analytical column (250 x 4.6 mm, 5μ). 1.0 ml/min of a mobile phase consisting of water and methanol (40:60v/v) for Leflunomide tablet formulation.

Results: The method showed excellent linear response with correlation coefficient (R2) values of 0.999 for a Leflunomide. The percent recoveries for a drug were found within the acceptance limit of (99.93%–100.34%). Intra-and inter-day precision studies of the new method were less than the maximum allowable limit percentage of relative standard deviation (%RSD) ≤ 2.0. It can be concluded from the results that the present method for validation determination of Leflunomide in tablets is specific, rapid, and simple with good sensitivity.

Conclusion: This analytical method is also applicable in ordinary laboratories and also technique may be used to measure the drug and assess the uniformity and purity of the dosage formulation as well as for quality control of commercial Leflunomide tablets.


Download data is not yet available.


Srinivas RV, Narasimha RM, Allam AR, Maheswari I, Srinubabu G. Development and validation of LC method for the determination of leflunomide in pharmaceutical formulations using an experimental design. Afr J Pure Appl Chem 2008;2(2):10-7.

Rastogi RP, Mehrotra BN. Compendium of Indian medicinal plants. Vol. 2. Lucknow and New Delhi: Central Drug Research Institute and National Institute of Science Communication; 1980. p. 473-5.

Schiff MH, Whelton A. editors. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum. 2000;30(3):196-208. doi: 10.1053/sarh.2000.16641, PMID 11124283.

Herrmann ML, Schleyerbach R, Kirschbaum BJ. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases. Immunopharmacology. 2000;47(2-3):273-89. doi: 10.1016/s0162-3109(00)00191-0, PMID 10878294.

Viviano KR. Pharmacotherapeutics of immune‐mediated disease. Pharmacother Vet Dispensing. 2019:339-60.

Gupta S, George M, Singhal M, Sharma GN, Garg V. Leaves extract of Murraya koenigii Linn for anti-inflammatory and analgesic activity in animal models. J Adv Pharm Technol Res. 2010;1(1):68-77. PMID 22247833.

Stomrud E, Bjorkqvist M, Janciauskiene S, Minthon L, Hansson O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res Ther. 2010;2(3):20. doi: 10.1186/alzrt44, PMID 20576109.

Nussbaumer S, Bonnabry P, Veuthey JL, Fleury Souverain S. Analysis of anticancer drugs: a review. Talanta. 2011;85(5):2265-89. doi: 10.1016/j.talanta.2011.08.034, PMID 21962644.

Srinubabu G, Raju ChA, Sarath N, Kumar PK, Rao JV. Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design. Talanta. 2007;71(3):1424-9. doi: 10.1016/j.talanta.2006.04.042, PMID 19071468.

Gokul P, Ravichandran S. Bioanalytical method development and validation for simultaneous estimation of lercanidipine and atenolol in human plasma by using RP-HPLC; 2017.

Gannu R, Yamsani VV, Rao YM. New RP‐HPLC method with UV‐detection for the determination of carvedilol in human serum. J Liq Chromatogr Relat Technol. 2007;30(11):1677-85. doi: 10.1080/10826070701224937.

Mendez AS, Steppe M, Schapoval EE. Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in the pharmaceutical dosage form. J Pharm Biomed Anal. 2003;33(5):947-54. doi: 10.1016/s0731-7085(03)00366-2, PMID 14656585.

Guichard N, Fekete S, Guillarme D, Bonnabry P, Fleury Souverain S. Computer-assisted UHPLC–MS method development and optimization for the determination of 24 antineoplastic drugs used in hospital pharmacy. J Pharm Biomed Anal. 2019;164:395-401. doi: 10.1016/j.jpba.2018.11.014, PMID 30439666.

Sebesta DW. Glycosidase induction in Pseudomonas stutzeri and properties of one of its amylases maltotetraohydrolase: University of London. Royal Holloway and United Kingdom: Bedford New College; 1987.

Sánchez Brunete C, Rodriguez A, Tadeo JL. Multiresidue analysis of carbamate pesticides in soil by sonication-assisted extraction in small columns and liquid chromatography. J Chromatogr A. 2003;1007(1-2):85-91. doi: 10.1016/s0021-9673(03)00953-1, PMID 12924554.

Ahmad S, Ahire S, Tamiya A. QbD approach method development and validation for the simultaneous estimation of methotrexate and folic acid by UV spectrophotometric and RP-HPLC in bulk and tablet dosage forms. Journal of Pharmaceutical Sciences and Research. 2021;13(9):553-8.

Sakhare R. Development and validation of a stability indicating RP-HPLC method for the determination of adefovir dipivoxil in bulk and tablet dosage form. Int J Pharm Res. 2015;7(4):25.

Horowitz AJ, Elrick KA, Colberg MR. The effect of membrane filtration artifacts on dissolved trace element concentrations. Water Res. 1992;26(6):753-63. doi: 10.1016/0043-1354(92)90006-P.

Kennedy VC, Zellweger GW, Jones BF. Filter pore‐size effects on the analysis of Al, Fe, Mn, and Ti in water. Water Resour Res. 1974;10(4):785-90. doi: 10.1029/WR010i004p00785.

Zhou G, Chen Y, Tang Y. Total content of piperidine analysis in artane by RP-HPLC using pre-column derivatization with 4-toluene sulfonyl chloride. J Chromatogr Sci. 2022;60(7):613-9. doi: 10.1093/chromsci/bmab099, PMID 34343261.

Zhang A, Wan L, Wu C, Fang Y, Han G, Li H. Simultaneous determination of 14 phenolic compounds in grape canes by HPLC-DAD-UV using wavelength switching detection. Molecules. 2013;18(11):14241-57. doi: 10.3390/molecules181114241, PMID 24252994.

Borman P, Elder D. Q2 [R1] validation of analytical procedures. ICH Quality Guidelines. 2017;5:127-66.

Schmidt A, Schwind B, Gillich M, Brune K, Hinz B. Simultaneous determination of leflunomide and its active metabolite, A77 1726, in human plasma by high‐performance liquid chromatography. Biomed Chromatogr. 2003;17(4):276-81. doi: 10.1002/bmc.244, PMID 12833393.

Shamonki MI, Spandorfer SD, Rosenwaks Z. Ultrasound-guided embryo transfer and the accuracy of trial embryo transfer. Hum Reprod. 2005;20(3):709-16. doi: 10.1093/humrep/deh546, PMID 15689350.

Chan V, Charles BG, Tett SE. Rapid determination of the active leflunomide metabolite A77 1726 in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;803(2):331-5. doi: 10.1016/j.jchromb.2004.01.016, PMID 15063344.

Abdelwahab NS, Abdelrahman MM, Boshra JM, Taha AA. Different stability-indicating chromatographic methods for specific determination of paracetamol, dantrolene sodium, their toxic impurities and degradation products. Biomed Chromatogr. 2019;33(9):e4598. doi: 10.1002/bmc.4598, PMID 31108565.

Alt FW, Kellems RE, Bertino JR, Schimke RT. Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured murine cells. J Biol Chem. 1978;253(5):1357-70. doi: 10.1016/S0021-9258(17)34875-5, PMID 627542.

Shabir GA. Validation of high-performance liquid chromatography methods for pharmaceutical analysis. Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization. J Chromatogr A. 2003;987(1-2):57-66. doi: 10.1016/s0021-9673(02)01536-4, PMID 12613797.

Sahu PK, Ramisetti NR, Cecchi T, Swain S, Patro CS, Panda J. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2018;147:590-611. doi: 10.1016/j.jpba.2017.05.006, PMID 28579052.

Bhatt DA, Rane SI. QbD approach to analytical RP-HPLC method development and its validation. Int J Pharm Pharm Sci. 2011;3(1):179-87.

Rao PP. A new method for the simultaneous estimation of methotrexate and folic acid by using RP-HPLC in the bulk and pharmaceutical dosage form. YMER Journal. 2022 July;21(7):880-90.

Chen J, Fu B, Liu T, Yan Z, Li K. A graphene oxide‐DNA electrochemical sensor based on glassy carbon electrode for sensitive determination of methotrexate. Electroanalysis. 2018;30(2):288-95. doi: 10.1002/elan.201700615.

Khoury S, Chouchou F, Amzica F, Giguere J, Denis R. The authors declare no conflicts of interest with the work presented in this manuscript. 2013.

Müller L, Mauthe RJ, Riley CM, Andino MM, Antonis DD, Beels C. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess the potential for genotoxicity. Regul Toxicol Pharmacol. 2006;44(3):198-211. doi: 10.1016/j.yrtph.2005.12.001, PMID 16412543.

Validation of analytical methods primer. ICH Q3A (R2), Impurities in New Drug Substances. Agilent publication; 2006. p. 5990-5140EN.

ICH. Validation of analytical procedures: definitions and methodology, Geneva. Vol. Q2 (R1); 2005. p. 2005.

Srinivasan G, Shetty A. Advancements in dry powder inhaler. Asian J Pharm Clin Res. 2017;10(2):8-12. doi: 10.22159/ajpcr.2017.v10i2.14282.

Liu DQ, Sun M, Kord AS. Recent advances in trace analysis of pharmaceutical genotoxic impurities. J Pharm Biomed Anal. 2010;51(5):999-1014. doi: 10.1016/j.jpba.2009.11.009, PMID 20022442.



How to Cite

NARESH, P., and K. V. KUMAR. “LEFLUNOMIDE TABLET FORMULATION: DEVELOPMENT AND VALIDATION OF AN RP-HPLC TECHNIQUE”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 15, no. 1, Jan. 2023, pp. 16-21, doi:10.22159/ijpps.2023v15i1.46505.



Original Article(s)